Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia

Clinical Endocrinology

Volumn 46, Issue 3, 1997, Pages 333-342

  Ho, P Jean ^a   Baxter, Robert C ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYCLOPHOSPHAMIDE; GONADORELIN DERIVATIVE; INSULIN LIKE GROWTH FACTOR PROTEIN 2; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOLOGY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; RADIOIMMUNOASSAY;

AGED; AGED, 80 AND OVER; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR II; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; TUMOR MARKERS, BIOLOGICAL;

EID: 0030896613     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Baxter, R.C. (1990) Radioimmunoassay for insulin-like growth factor (IGF) II: interference by pure IGF-binding proteins. Journal of Immunoassay, 11, 445-458.
2. Baxter, R.C. (1993) Circulating binding proteins for the insulinlike growth factors. Trends in Endocrinology and Metabolism, 4, 91-96.
3. Baxter, R.C., Brown, A.S. & Turtle, J.R. (1982) Radioimmunoassay for somatomedin-C: comparison with radioreceptor assay in patients with growth hormone disorders, hypothyroidism and renal failure. Clinical Chemistry, 28, 488-495.
4. Baxter, R.C., Holman, S.R., Corbould, A., Stranks, S., Ho, P.J. & Braund, W. (1995) Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hyoglycemia. Journal of Clinical Endocrinology and Metabolism, 80, 2700-2708.
5. Baxter, R.C. & Martin, J.L. (1986) Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding in human plasma. Journal of Clinical Investigation, 78, 1504-1512.
6. Bicsak, T.A., Motoyuki, S., Malkowaski, M. & Ling, N. (1990) Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3′,5′-monophosphate, deoxribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology, 126, 2184-2189.
7. Blum, W.F., Horn, N., Kratzsch, J., Jorgensen, J.O.L., Juul, A., Teale, D., Mohnike, K. & Ranke, M.B. (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regulation, 3, 100-104.
8. Blum, W.F., Jenne, E.W., Reppin, F., Kietzman, K., Ranke, M.B. & Bierich, J.R. (1989) Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology, 125, 766-772.
9. Booth, B.A., Bar, R.S., Boes, M., Dake, B.L., Bayne, M. & Cascieri, M. (1990) Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells. Endocrinology, 127, 2630-2638.
10. Bourner, M.J., Busby, W.H., Jr, Siegel, N.R., Krivi, G.G., McCusker, R.H. & Clemmons, D. (1992) Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of the structural and functional properties with IGFBP-1. Journal of Cellular Biochemistry, 48, 215-226.
11. Chen, J.-C., Shao, Z.-M., Sheikh, M.S., Hussain, A., LeRoith, D., Roberts, C.T. & Fontana, J.A. (1994) Insulin-like binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. Journal of Cellular Physiology, 158, 69-78.
12. Clemmons, D.R., Snyder, D.K. & Busby, W.H. (1991) Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. Journal of Clinical Endocrinology and Metabolism, 73, 727-733.
13. Cohen, P., Graves, H.C.B., Peehl, D.M., Kameri, M., Guidice, L.C. & Rosenfeld, R.G. (1992) Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. Journal of Clinical Endocrinology and Metabolism, 75, 1046-1053.
14. Cohen, P., Peehl, D.M., Baker, B., Liu, F., Hintz, R.L. & Rosenfeld, R.G. (1994a) Insulin-like growth factor abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. Journal of Clinical Endocrinology and Metabolism, 79, 1410-1415.
15. Cohen, P., Peehl, D.M. & Rosenfeld, R.G. (1994b) The IGF axis in the prostate. Hormone and Metabolic Research, 26, 81-84.
16. Cohen, P., Peehl, D.M., Stamey, T.A., Wilson, K.F., Clemmons, D.R. & Rosenfeld, R.G. (1993) Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. Journal of Clinical Endocrinology and Metabolism, 76, 1031-1035.
17. Collins, G.N., Lee, R.J., McKelvie, G.B., Rogers, A.C.N. & Hehir, M. (1993) Relationship between prostate specific antigen, prostate volume and age in the benign prostate. British Journal of Urology, 71, 445-450.
18. Conover, C.A., Perry, J.E. & Tindall, D.J. (1995) Endogenous cathepsin o-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. Journal of Clinical Endocrinology and Metabolism, 80, 987-993.
19. Davies, S.C., Wass, J.A.H., Ross, R.J.M., Cotterill, A.M., Buchanan, C.R., Coulson, V.J. & Holly, J.M.P. (1991) The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. Journal of Endocrinology, 130, 469-473.
20. De Mellow, J.S.M. & Baxter, R.C. (1988) Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochemical and Biophysical Research Communications, 156, 199-204.
21. DeAntoni, E., Crawford, E.D., Stone, N.N., Blum, D.S., Berger, E.R., Eisenberger, M.A., Gambert, S.R. & Staggers, F. (1993) Prostate cancer awareness week, 1992: a summary of key findings. Clinical and Investigative Medicine, 16, 448-457.
22. Delhanty, P.J.D. & Han, V.K.M. (1993) An RGD to RGE mutation in the putative membrane binding domain of the IGFBP-2 inhibits its potentiation of IGF-II induced thymidine uptake by SCP cells. Proceedings of the 75th Annual Meeting of the Endocrine Society, Abstract 22.
23. Elgin, R.G., Busby, W.H., Jr & Clemmons, D.R. (1987) An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proceedings of the National Academy of Science USA, 84, 3254-3258.
24. Jones, J.I. & Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews. 16, 3-34.
25. Kanety, H., Madjar, Y., Dagan, Y., Levi, J., Papa, M.Z., Pariente, C., Gooldwasser, B. & Karasik, A. (1993) Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. Journal of Clinical Endocrinology and Metabolism, 77, 229-233.
26. LeRoith, D., Clemmons, D., Nissley, P. & Rechler, M.M. (1992) Insulin-like growth factors in health and disease. Annals of Internal Medicine, 116, 854-862.
27. Martin, J.L. & Baxter, R.C. (1986) Insulin-like growth factor-binding protein from human plasma. Purification and characterization. Journal of Biological Chemistry, 261, 8754-8760.
28. Miell, J.P., Taylor, A.M., Jones, J., Holly, J.M.P., Gaillard, R.C., Pralong, F.P., Ross, R.J.M. & Blum, W.F. (1993) The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. Journal of Endocrinology, 136, 525-533.
29. Muller, H.L., Oh, Y., Lehrnbecher, T., Blum, W.F. & Rosenfeld, R.G. (1994) Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. Journal of Clinical Endocrinology and Metabolism, 79, 428-434.
30. Oesterling, J.E., Cooner, W.H., Jacobsen, S.T., Guess, H.A. & Lieber, M.M. (1993a) Influence of patient age on the serum PSA concentration. An important clinical observation. Urologic Clinics of North America, 20, 671-680.
31. Oesterling, J.E., Jacobsen, S.J., Chute, C.G., Guess, H.A., Girman, C.J., Panser, L.A. & Lieber, M.M. (1993b) Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. Journal of the American Medical Association, 270, 860-864.
32. Petros, J.A. & Andriole, G.L. (1993) Serum PSA after antiandrogen therapy. Urologic Clinics of North America, 20, 749-756.
33. Reeve, J.G., Kirby, L.B., Brinkman, A., Hughes, S.A., Schwander, J. & Blechen, N.M. (1992) Insulin-like growth-factor protein gene expression and protein production by human tumour cell lines. International Journal of Cancer, 51, 818-821.
34. Reeve, J.G., Payne, J.A. & Bleehan, N.M. (1990) Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours. British Journal of Cancer, 61, 727-731.
35. Sagalowsky, A.I. & Wilson, J.D. (1994) Hyperplasia and carcinoma of the prostate. In Harrisons's Principles of Internal Medicine (ed. K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci & D.L. Kasper), pp. 1862-1865. McGraw-Hill, New York.
36. Schwander, J. & Mary, J.L. (1993) The RIA for IGFBP-2 in man- a meagre catch? Growth Regulation, 3, 104-108.
37. Sikaris, K.A. (1996) Prostate specific antigen. The Clinical Biochemist-Reviews. 17, 50-68.
38. Stamey, T.A., Ekman, P.E., Blandenstein, M.A., Cooper, E.H., Kontturi, M., Lilja, H., Oesterling, J.E., Stenman, U.-H. & Turkes, A. (1994) Tumor markers. Scandinavian Journal of Urology and Nephrology, 162(Suppl.) 73-87.
39. Tennant, M.K., Thrasher, J.B., Twomey, P.A., Birnbaum, R.S. & Plymate, S.R. (1996) Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate intraepithelial neoplasia and adenocarcinoma of the prostate. Journal of Clinical Endocrinology and Metabolism, 81, 411-420.
40. Zapf, J. (1995) Physiological role of the insulin-like growth factor binding proteins. European Journal of Endocrinology, 132, 645-654.
41. Zapf, J., Schmid, C., Guler, H.P., Waldvogel, M., Hauri, C., Futo, E., Hossenlopp, P., Binoux, M. & Froesch, E.R. (1990) Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein-2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycaemia. Journal of Clinical Investigation, 86, 952-961.
42. Zumkeller, W., Schwander, J., Mitchell, C.D., Morrell, D.J., Schofield, P.N. & Preece, M.A. (1993) Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour. European Journal of Cancer, 29A, 1973-1993.